Article Versions Notes

Cheema PK, Iafolla MAJ, Abdel-Qadir H, Bellini AB, Chatur N, Chandok N, Comondore VR, Cunningham M, Halperin I, Hu AB, et al. Managing Select Immune-Related Adverse Events in Patients Treated with Immune Checkpoint Inhibitors. Current Oncology. 2024; 31(10):6356-6383. https://doi.org/10.3390/curroncol31100473

Cheema, Parneet K., Marco A. J. Iafolla, Husam Abdel-Qadir, Andrew B. Bellini, Nazira Chatur, Natasha Chandok, Vikram R. Comondore, Morven Cunningham, Ilana Halperin, Anne B. Hu, and et al. 2024. "Managing Select Immune-Related Adverse Events in Patients Treated with Immune Checkpoint Inhibitors" Current Oncology 31, no. 10: 6356-6383. https://doi.org/10.3390/curroncol31100473

Cheema, P. K., Iafolla, M. A. J., Abdel-Qadir, H., Bellini, A. B., Chatur, N., Chandok, N., Comondore, V. R., Cunningham, M., Halperin, I., Hu, A. B., Jaskolka, D., Darvish-Kazem, S., Khandaker, M. H., Kitchlu, A., Sachdeva, J. S., Shapera, S., Woolnough, N. R. J., & Nematollahi, M. (2024). Managing Select Immune-Related Adverse Events in Patients Treated with Immune Checkpoint Inhibitors. Current Oncology, 31(10), 6356-6383. https://doi.org/10.3390/curroncol31100473